52 related articles for article (PubMed ID: 32040552)
1. T-cell prolymphocytic leukemia/lymphoma with TCRB::TCL1 translocation.
Torabi A; Naresh KN
Blood; 2023 Jul; 142(1):119. PubMed ID: 37410504
[No Abstract] [Full Text] [Related]
2. BH3 profiling identifies ruxolitinib as a promising partner for venetoclax to treat T-cell prolymphocytic leukemia.
Herbaux C; Kornauth C; Poulain S; Chong SJF; Collins MC; Valentin R; Hackett L; Tournilhac O; Lemonnier F; Dupuis J; Daniel A; Tomowiak C; Laribi K; Renaud L; Roos-Weil D; Rossi C; Van Den Neste E; Leyronnas C; Merabet F; Malfuson JV; Tiab M; Ysebaert L; Ng S; Morschhauser F; Staber PB; Davids MS
Blood; 2021 Jun; 137(25):3495-3506. PubMed ID: 33598678
[TBL] [Abstract][Full Text] [Related]
3. Prolymphocytic Leukaemia: an Update on Biology and Treatment.
El-Sharkawi D; Dearden C
Curr Oncol Rep; 2024 Feb; 26(2):129-135. PubMed ID: 38214879
[TBL] [Abstract][Full Text] [Related]
4. The mitochondrial anti-apoptotic dependencies of hematologic malignancies: from disease biology to advances in precision medicine.
Ferrarini I; Rigo A; Visco C
Haematologica; 2022 Apr; 107(4):790-802. PubMed ID: 35045693
[TBL] [Abstract][Full Text] [Related]
5. Hijacking the Pathway: Perspectives in the Treatment of Mature T-cell Leukemias.
Wahnschaffe L; Herling M
Hemasphere; 2021 Jun; 5(6):e573. PubMed ID: 34095757
[No Abstract] [Full Text] [Related]
6. Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia.
Hampel PJ; Parikh SA; Call TG; Shah MV; Bennani NN; Al-Kali A; Rabe KG; Wang Y; Muchtar E; Leis JF; Kenderian SS; Koehler AB; Schwager SM; Slager SL; Kay NE; Hanson CA; Van Dyke DL; Shi M; Ding W
Blood Cancer J; 2021 Mar; 11(3):47. PubMed ID: 33654067
[No Abstract] [Full Text] [Related]
7. Rationale for the combination of venetoclax and ibrutinib in T-prolymphocytic leukemia.
Kornauth C; Herbaux C; Boidol B; Guillemette C; Caron P; Mayerhöfer ME; Poulain S; Tournilhac O; Pemovska T; Chong SJF; Van der Kouwe E; Kazianka L; Hopfinger G; Heintel D; Jäger R; Raderer M; Jäger U; Simonitsch-Klupp I; Sperr WR; Kubicek S; Davids MS; Staber PB
Haematologica; 2021 Aug; 106(8):2251-2256. PubMed ID: 33626863
[No Abstract] [Full Text] [Related]
8. MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents.
Bolomsky A; Vogler M; Köse MC; Heckman CA; Ehx G; Ludwig H; Caers J
J Hematol Oncol; 2020 Dec; 13(1):173. PubMed ID: 33308268
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the anti-apoptotic protein MCL-1 severely suppresses human hematopoiesis.
Bohler S; Afreen S; Fernandez-Orth J; Demmerath EM; Molnar C; Wu Y; Weiss JM; Mittapalli VR; Konstantinidis L; Schmal H; Kunze M; Erlacher M
Haematologica; 2021 Dec; 106(12):3136-3148. PubMed ID: 33241675
[TBL] [Abstract][Full Text] [Related]
10. Prolymphocytic Leukemia: New Insights in Diagnosis and in Treatment.
Collignon A; Wanquet A; Maitre E; Cornet E; Troussard X; Aurran-Schleinitz T
Curr Oncol Rep; 2017 Apr; 19(4):29. PubMed ID: 28324286
[TBL] [Abstract][Full Text] [Related]
11. BCL2 Inhibitors as Anticancer Drugs: A Plethora of Misleading BH3 Mimetics.
S Soderquist R; Eastman A
Mol Cancer Ther; 2016 Sep; 15(9):2011-7. PubMed ID: 27535975
[TBL] [Abstract][Full Text] [Related]
12. Dual dependence on BCL2 and MCL1 in T-cell prolymphocytic leukemia.
Smith VM; Lomas O; Constantine D; Palmer L; Schuh AH; Bruce D; Gonchar O; Macip S; Jayne S; Dyer MJS; Eyre TA
Blood Adv; 2020 Feb; 4(3):525-529. PubMed ID: 32040552
[TBL] [Abstract][Full Text] [Related]
13. Enhanced stability of Mcl1, a prosurvival Bcl2 relative, blunts stress-induced apoptosis, causes male sterility, and promotes tumorigenesis.
Okamoto T; Coultas L; Metcalf D; van Delft MF; Glaser SP; Takiguchi M; Strasser A; Bouillet P; Adams JM; Huang DC
Proc Natl Acad Sci U S A; 2014 Jan; 111(1):261-6. PubMed ID: 24363325
[TBL] [Abstract][Full Text] [Related]
14. Targeting of BCL2 Family Proteins with ABT-199 and Homoharringtonine Reveals BCL2- and MCL1-Dependent Subgroups of Diffuse Large B-Cell Lymphoma.
Klanova M; Andera L; Brazina J; Svadlenka J; Benesova S; Soukup J; Prukova D; Vejmelkova D; Jaksa R; Helman K; Vockova P; Lateckova L; Molinsky J; Maswabi BC; Alam M; Kodet R; Pytlik R; Trneny M; Klener P
Clin Cancer Res; 2016 Mar; 22(5):1138-49. PubMed ID: 26467384
[TBL] [Abstract][Full Text] [Related]
15. The selectivity of Marinopyrrole A to induce apoptosis in MCL1
Gomez-Bougie P; Dousset C; Descamps G; Schnitzler A; Audiger L; Tessier A; Dubreuil D; Lebreton J; Pellat-Deceunynck C; Amiot M
Br J Haematol; 2018 Jan; 180(1):157-159. PubMed ID: 27523575
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
